Currently, there is a Phase 1 trial recruiting patients with relapsed osteosarcoma and Ewing sarcoma for a trial of treatment with C7R (functionally active CD34-IL-7R) CAR-T cells (NCT03635632). This evidence concerns the gene CD34 and Ewing sarcoma.